Esben Schjødt Worm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Esben Schjødt Worm has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Per Rugaard Poulsen
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
3 shared publications - Britta Weber
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
2 shared publications - Morten Høyer
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark
2 shared publications - Alireza Zirak
Photonics and Quantum Technologies Research School, Nuclear Science and Technology Research Institute, Tehran, Iran
1 shared publication - Hanna Rahbek Mortensen
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus 8200, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus 8200, Denmark
1 shared publication Jakob Borup Thomsen
Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus 8200, Denmark
1 shared publication
Latest Publications
- Open Access
- 3 June 2026
- Published by Elsevier in Physica Medica
- Vol. 147, 105830
Respiratory gated proton therapy for liver cancer: Setup and gating validation based on fiducial marker motion extracted from 2D kV projection images acquired during cone-beam CT
- 3 June 2026
- Published by Elsevier in Physica Medica
- Vol. 147, 105830
Open AccessRespiratory gated proton therapy for liver cancer: Setup and gating validation based on fiducial marker motion extracted from 2D kV projection images acquired during cone-beam CT
- 1 July 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (14) , 145010
Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy
The accuracy of stereotactic body radiotherapy (SBRT) in the liver is limited by tumor motion. Selection of the most suitable motion mitigation strategy requires good understanding of the geometric and dosimetric consequences. This study compares the geometric and dosimetric accuracy of actually delivered respiratory gated SBRT treatments for 15 patients with liver tumors with three simulated alternative motion adaptation strategies. The simulated alternatives are MLC tracking, baseline shift adaptation by inter-field couch corrections and no intrafraction motion adaptation. The patients received electromagnetic transponder-guided respiratory gated IMRT or conformal treatments in three fractions with a 3–4 mm gating window around the full exhale position. The CTV-PTV margin was 5 mm axially and 7–10 mm cranio-caudally. The CTV and PTV were covered with 95% and 67% of the prescribed mean CTV dose, respectively. The time-resolved target position error during treatments with the four investigated motion adaptation strategies was used to calculate motion margins and the motion-induced reduction in CTV D 95 relative to the planned dose (Δ D 95 ). The mean (range) number of couch corrections per treatment session to compensate for tumor drift was 2.8 (0–7) with gating, 1.4 (0–5) with baseline shift adaptation, and zero for the other strategies. The motion margins were 3.5 mm (left–right), 9.4 mm (cranio–caudal) and 3.9 mm (anterior–posterior) without intrafraction motion adaptation, approximately half of that with baseline shift adaptation, and 1–2 mm with MLC tracking and gating. With 7 mm CC margins the mean (range) of Δ D 95 for the CTV was 8.1 (0.6–29.4)%-points (no intrafraction motion adaptation), 4.0 (0.4–13.3)%-points (baseline shift adaptation), 1.0 (0.3–2.2)%-points (MLC tracking) and 0.8 (0.1–1.8)%-points (gating). With 10 mm CC margins Δ D 95 was instead 4.8 (0.3–14.8)%-points (no intrafraction motion adaptation) and 2.9 (0.2–9.8)%-points (baseline shift adaptation). In conclusion, baseline shift adaptation can mitigate gross dose deficits without the requirement of real-time motion adaptation. MLC tracking and gating, however, more effectively ensure high similarity between planned and delivered doses.
- 1 July 2018
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 63 (14) , 145010
Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy
The accuracy of stereotactic body radiotherapy (SBRT) in the liver is limited by tumor motion. Selection of the most suitable motion mitigation strategy requires good understanding of the geometric and dosimetric consequences. This study compares the geometric and dosimetric accuracy of actually delivered respiratory gated SBRT treatments for 15 patients with liver tumors with three simulated alternative motion adaptation strategies. The simulated alternatives are MLC tracking, baseline shift adaptation by inter-field couch corrections and no intrafraction motion adaptation. The patients received electromagnetic transponder-guided respiratory gated IMRT or conformal treatments in three fractions with a 3–4 mm gating window around the full exhale position. The CTV-PTV margin was 5 mm axially and 7–10 mm cranio-caudally. The CTV and PTV were covered with 95% and 67% of the prescribed mean CTV dose, respectively. The time-resolved target position error during treatments with the four investigated motion adaptation strategies was used to calculate motion margins and the motion-induced reduction in CTV D 95 relative to the planned dose (Δ D 95 ). The mean (range) number of couch corrections per treatment session to compensate for tumor drift was 2.8 (0–7) with gating, 1.4 (0–5) with baseline shift adaptation, and zero for the other strategies. The motion margins were 3.5 mm (left–right), 9.4 mm (cranio–caudal) and 3.9 mm (anterior–posterior) without intrafraction motion adaptation, approximately half of that with baseline shift adaptation, and 1–2 mm with MLC tracking and gating. With 7 mm CC margins the mean (range) of Δ D 95 for the CTV was 8.1 (0.6–29.4)%-points (no intrafraction motion adaptation), 4.0 (0.4–13.3)%-points (baseline shift adaptation), 1.0 (0.3–2.2)%-points (MLC tracking) and 0.8 (0.1–1.8)%-points (gating). With 10 mm CC margins Δ D 95 was instead 4.8 (0.3–14.8)%-points (no intrafraction motion adaptation) and 2.9 (0.2–9.8)%-points (baseline shift adaptation). In conclusion, baseline shift adaptation can mitigate gross dose deficits without the requirement of real-time motion adaptation. MLC tracking and gating, however, more effectively ensure high similarity between planned and delivered doses.
- 1 May 2012
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 83 (1) , e145-e151
On-Line Use of Three-Dimensional Marker Trajectory Estimation From Cone-Beam Computed Tomography Projections for Precise Setup in Radiotherapy for Targets With Respiratory Motion
- 1 May 2012
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 83 (1) , e145-e151
On-Line Use of Three-Dimensional Marker Trajectory Estimation From Cone-Beam Computed Tomography Projections for Precise Setup in Radiotherapy for Targets With Respiratory Motion